Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB

• Yi Wang,
• Xiaoyan Pan,
• Hongying Ji,
• Xiaoli Zuo,
• Geng-Fu Xiao,
• Jia Li,
• Lei-Ke Zhang,
• Bingqing Xia,
• Zhaobing Gao

Affiliations

Yi Wang

Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Xiaoyan Pan

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences

Hongying Ji

Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Xiaoli Zuo

Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Geng-Fu Xiao

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences

Jia Li

Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Lei-Ke Zhang

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences

Bingqing Xia

Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Zhaobing Gao

Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences